Results 81 to 90 of about 6,014 (171)

ATP-Dependent Persister Formation in Escherichia coli

mBio, 2017
Persisters are dormant variants that form a subpopulation of cells tolerant to antibiotics. Persisters are largely responsible for the recalcitrance of chronic infections to therapy.
Yue Shan, Autumn Brown Gandt, Sarah E. Rowe, Julia P. Deisinger, Brian P. Conlon, Kim Lewis   +5 more
doaj   +1 more source

TETANUS AND ITS ANTITOXIN. [PDF]

The Lancet, 1917
n ...
openaire   +1 more source

Neurotropic Effect of Botulinum Toxin and the Potential of Specific Serum Therapy in Botulism (Review)

Безопасность и риск фармакотерапии
INTRODUCTION. The outbreak of foodborne botulism that occurred in Russia in June 2024 once again demonstrated the danger of this rather rare but severe infectious disease caused by ingesting botulinum neurotoxin.
E. M. Eliseeva, I. A. Mazerkina, A. A. Chistokhina   +2 more
doaj   +1 more source

A simple BLASTn-based approach generates novel insights into the regulation and biological function of type I toxin-antitoxins

mSystems
Bacterial chromosomal type I toxin-antitoxin systems consist of a small protein, typically under 60 amino acids, and a small RNA (sRNA) that represses toxin translation.
Selene F. H. Shore, Michael Ptacek, Andrew D. Steen, Elizabeth M. Fozo   +3 more
doaj   +1 more source

Molecular Detection of Type II Toxin RelE Gene and Relation with Biofilm Formation in Escherichia Coli

Ibn Al-Haitham Journal for Pure and Applied Sciences
Escherichia coli is the principal etiological agent of urinary tract infections (UTIs) and exhibits significant antibiotic resistance, driven by various virulence factors. Fifty E.
Areej Jasem Mohammad, Enass Ghassan Sweedan   +1 more
doaj   +1 more source

On a Dysentery Antitoxin [PDF]

The American Journal of the Medical Sciences, 1903
openaire   +2 more sources

Inducible auto-phosphorylation regulates a widespread family of nucleotidyltransferase toxins

Nature Communications
Nucleotidyltransferases (NTases) control diverse physiological processes, including RNA modification, DNA replication and repair, and antibiotic resistance.
Tom J. Arrowsmith, Xibing Xu, Shangze Xu, Ben Usher, Peter Stokes, Megan Guest, Agnieszka K. Bronowska, Pierre Genevaux, Tim R. Blower   +8 more
doaj   +1 more source

Intubation and Antitoxin [PDF]

BMJ, 1897
openaire   +2 more sources

Type II Toxin-Antitoxin Systems in Escherichia coli

Infection and Drug Resistance
He Zhang,1 Shuan Tao,2 Huimin Chen,2 Yewei Fang,2 Yao Xu,3 A-Xiang Han,2 Fang Ma,1,* Wei Liang2,* 1Department of Medical Laboratory, Bengbu Medical University, Bengbu, Anhui, People’s Republic of China; 2Department of Clinical Laboratory, The ...
Zhang H, Tao S, Chen H, Fang Y, Xu Y, Han AX, Ma F, Liang W   +7 more
doaj  

Reply to Holden and Errington, “Type II Toxin-Antitoxin Systems and Persister Cells”

mBio, 2018
Frédéric Goormaghtigh, Nathan Fraikin, Marta Putrinš, Vasili Hauryliuk, Abel Garcia-Pino, Klas Udekwu, Tanel Tenson, Niilo Kaldalu, Laurence Van Melderen   +8 more
doaj   +1 more source